From theory to therapy.Creating homeostatic harmony by downregulation of oxidative stress response and improving mitochondrial dysfunction.
Company Allegro is redefining the treatment of ocular diseases with integrin-regulating therapy. more…
Science Our mechanism of action (MOA) focuses on the disruption of integrin functions. more…
Pipeline Allegro seeks to uncover groundbreaking treatments for eye care patients who have limited or no options, or who inadequately respond to existing therapies. more…
Therapeutic Areas Allegro focuses on ocular diseases with unmet needs such as intermediate dry AMD and dry eye disease. more…
Company
Allegro is redefining the treatment of ocular diseases with integrin-regulating therapy. more…
Science
Pipeline
Allegro seeks to uncover groundbreaking treatments for eye care patients who have limited or no options, or who inadequately respond to existing therapies. more…
Therapeutic Areas
Allegro focuses on ocular diseases with unmet needs such as intermediate dry AMD and dry eye disease. more…
